Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 201629, 10 pages
http://dx.doi.org/10.1155/2015/201629
Research Article

Decorin-Mediated Inhibition of Human Trophoblast Cells Proliferation, Migration, and Invasion and Promotion of Apoptosis In Vitro

1Department of Obstetrics and Gynecology, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing 210029, China
2Department of General Surgery, The Second Affiliated Hospital of Nanjing Medical University, 121 Jiangjiayuan, Xiaguan District, Nanjing 210000, China

Received 19 September 2014; Accepted 5 March 2015

Academic Editor: Shi-Wen Jiang

Copyright © 2015 Yanfen Zou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. A. P. Steegers, P. von Dadelszen, J. J. Duvekot, and R. Pijnenborg, “Pre-eclampsia,” The Lancet, vol. 376, no. 9741, pp. 631–644, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. S. T. Peter, T. O. Scholl, M. D. Schluter et al., “Oxidative stress early in pregnancy and pregnancy outcome,” Free Radical Research, vol. 42, no. 10, pp. 841–848, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. G. P. Sacks, K. Studena, I. L. Sargent, and C. W. G. Redman, “Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis,” American Journal of Obstetrics and Gynecology, vol. 179, no. 1, pp. 80–86, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. A. F. Saftlas, H. Beydoun, and E. Triche, “Immunogenetic determinants of preeclampsia and related pregnancy disorders: a systematic review,” Obstetrics & Gynecology, vol. 106, no. 1, pp. 162–172, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. K. P. Conrad and D. F. Benyo, “Placental cytokines and the pathogenesis of preeclampsia,” American Journal of Reproductive Immunology, vol. 37, no. 3, pp. 240–249, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. J. P. Granger, B. T. Alexander, M. T. Llinas, W. A. Bennett, and R. A. Khalil, “Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction,” Hypertension, vol. 38, no. 3, part 2, pp. 718–722, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Rana, S. A. Karumanchi, R. J. Levine et al., “Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia,” Hypertension, vol. 50, no. 1, pp. 137–142, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Lam, K.-H. Lim, and S. A. Karumanchi, “Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia,” Hypertension, vol. 46, no. 5, pp. 1077–1085, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Noris, M. Todeschini, P. Cassis et al., “L-arginine depletion in preeclampsia orients nitric oxide synthase toward oxidant species,” Hypertension, vol. 43, no. 3, pp. 614–622, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. S. W. Walsh, “Maternal-placental interactions of oxidative stress and antioxidants in preeclampsia,” Seminars in Reproductive Endocrinology, vol. 16, no. 1, pp. 93–104, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. J. L. Bartha, R. Romero-Carmona, R. Torrejon-Cardoso, and R. Comino-Delgado, “Insulin, insulin-like growth factor-1, and insulin resistance in women with pregnancy-induced hypertension,” American Journal of Obstetrics and Gynecology, vol. 187, no. 3, pp. 735–740, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. G. J. Burton and H. W. Yung, “Endoplasmic reticulum stress in the pathogenesis of early-onset pre-eclampsia,” Pregnancy Hypertension, vol. 1, no. 1, pp. 72–78, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. A. E. P. Heazell, H. R. Buttle, P. N. Baker, and I. P. Crocker, “Altered expression of regulators of caspase activity within trophoblast of normal pregnancies and pregnancies complicated by preeclampsia,” Reproductive Sciences, vol. 15, no. 10, pp. 1034–1043, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. J. M. Roberts and H. S. Gammill, “Preeclampsia: recent insights,” Hypertension, vol. 46, no. 6, pp. 1243–1249, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Pijnenborg, L. Vercruysse, and M. Hanssens, “The uterine spiral arteries in human pregnancy: facts and controversies,” Placenta, vol. 27, no. 9-10, pp. 939–958, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Basak and A. K. Duttaroy, “Effects of fatty acids on angiogenic activity in the placental extravillious trophoblast cells,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 88, no. 2, pp. 155–162, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. R. V. Iozzo, D. K. Moscatello, D. J. McQuillan, and I. Eichstetter, “Decorin is a biological ligand for the epidermal growth factor receptor,” The Journal of Biological Chemistry, vol. 274, no. 8, pp. 4489–4492, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. J. J. Lysiak, J. Hunt, G. A. Pringle, and P. K. Lala, “Localization of transforming growth factor β and its natural inhibitor decorin in the human placenta and decidua throughout gestation,” Placenta, vol. 16, no. 3, pp. 221–231, 1995. View at Publisher · View at Google Scholar · View at Scopus
  19. A. U. Borbely, S. Daher, M. M. Ishigai et al., “Decorin and biglycan immunolocalization in non-villous structures of healthy and pathological human placentas,” Histopathology, vol. 64, no. 5, pp. 616–625, 2014. View at Publisher · View at Google Scholar
  20. D. Iacob, J. Cai, M. Tsonis et al., “Decorin-mediated inhibition of proliferation and migration of the human trophoblast via different tyrosine kinase receptors,” Endocrinology, vol. 149, no. 12, pp. 6187–6197, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Lala, G. V. Girish, A. Cloutier-Bosworth, and P. K. Lala, “Mechanisms in decorin regulation of vascular endothelial growth factor-induced human trophoblast migration and acquisition of endothelial phenotype,” Biology of Reproduction, vol. 87, no. 3, article 59, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. C. C. Reed and R. V. Iozzo, “The role of decorin in collagen fibrillogenesis and skin homeostasis,” Glycoconjugate Journal, vol. 19, no. 4-5, pp. 249–255, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. A. S. Hamid, J. Li, Y. Wang et al., “Recombinant human decorin upregulates P57KIP2 expression in HepG2 hepatoma cell lines,” Molecular Medicine Reports, vol. 8, no. 2, pp. 511–516, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. B. P. Toole, “Solubility of collagen fibrils formed in vitro in the presence of sulphated acid mucopolysaccharide-protein,” Nature, vol. 222, no. 196, pp. 872–873, 1969. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Ständer, U. Naumann, W. Wick, and M. Weller, “Transforming growth factor-β and p-21: multiple molecular targets of decorin-mediated suppression of neoplastic growth,” Cell and Tissue Research, vol. 296, no. 2, pp. 221–227, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. C. H. Graham, T. S. Hawley, R. G. Hawley et al., “Establishment and characterization of first trimester human trophoblast cells with extended lifespan,” Experimental Cell Research, vol. 206, no. 2, pp. 204–211, 1993. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Kitroser, M. Pomeranz, S. G. Epstein et al., “The involvement of eukaryotic translation initiation factor 4E in extravillous trophoblast cell function,” Placenta, vol. 33, no. 9, pp. 717–724, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Liu, Q. Li, Q. Na, and C. Liu, “Endothelin-1 stimulates human trophoblast cell migration through Cdc42 activation,” Placenta, vol. 33, no. 9, pp. 712–716, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. X. Bi, N. M. Pohl, Z. Qian et al., “Decorin-mediated inhibition of colorectal cancer growth and migration is associated with E-cadherin in vitro and in mice,” Carcinogenesis, vol. 33, no. 2, pp. 326–330, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Santra, T. Skorski, B. Calabretta, E. C. Lattime, and R. V. Iozzo, “De novo decorin gene expression suppresses the malignant phenotype in human colon cancer cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 15, pp. 7016–7020, 1995. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Troup, C. Njue, E. V. Kliewer et al., “Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer,” Clinical Cancer Research, vol. 9, no. 1 I, pp. 207–214, 2003. View at Google Scholar · View at Scopus
  32. A. de Luca, M. Santra, A. Baldi, A. Giordano, and R. V. Iozzo, “Decorin-induced growth suppression is associated with up-regulation of p21, an inhibitor of cyclin-dependent kinases,” The Journal of Biological Chemistry, vol. 271, no. 31, pp. 18961–18965, 1996. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Chui, P. Murthi, S. P. Brennecke, V. Ignjatovic, P. T. Monagle, and J. M. Said, “The expression of placental proteoglycans in pre-eclampsia,” Gynecologic and Obstetric Investigation, vol. 73, no. 4, pp. 277–284, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. J.-X. Zhu, S. Goldoni, G. Bix et al., “Decorin evokes protracted internalization and degradation of the epidermal growth factor receptor via caveolar endocytosis,” Journal of Biological Chemistry, vol. 280, no. 37, pp. 32468–32479, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. E. Schönherr, C. Sunderkötter, R. V. Iozzo, and L. Schaefer, “Decorin, a novel player in the insulin-like growth factor system,” The Journal of Biological Chemistry, vol. 280, no. 16, pp. 15767–15772, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. G. F. Guidetti, B. Bartolini, B. Bernardi et al., “Binding of von Willebrand factor to the small proteoglycan decorin,” FEBS Letters, vol. 574, no. 1–3, pp. 95–100, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. T. Y. Khong, F. de Wolf, W. B. Robertson, and I. Brosens, “Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants,” British Journal of Obstetrics and Gynaecology, vol. 93, no. 10, pp. 1049–1059, 1986. View at Publisher · View at Google Scholar · View at Scopus
  38. S. J. Fisher, M. S. Leitch, M. S. Kantor, C. B. Basbaum, and R. H. Kramer, “Degradation of extracellular matrix by the trophoblastic cells of first-trimester human placentas,” Journal of Cellular Biochemistry, vol. 27, no. 1, pp. 31–41, 1985. View at Publisher · View at Google Scholar · View at Scopus
  39. I. M. Rasstrigina, A. P. Milovanov, T. V. Fokina, and M. Kadyrov, “The intensity of expression of matrix metalloproteinases type 2 and type 9 by invasive trophoblast cells in uncomplicated pregnancy and preeclampsia,” Arkhiv Patologii, vol. 76, no. 3, pp. 24–29, 2014. View at Google Scholar